European Stroke Journal (ESJ)

About ESJ

The European Stroke Journal (ESJ) is the official journal of the ESO. A subscription and hard copy of the ESJ is included as a benefit of ESO membership.

The ESJ has had a good start and we have set ambitious goals to continue developing the journal. In order to reach these goals, we need your support, please continue to submit your best science to the ESJ. We welcome original research articles, reviews, guidelines, and clinical trial protocols. After seeing all of the impressive work presented at the ESOC, we know there is great research waiting to be published. By submitting your research and actively supporting the ESJ, you support the development of stroke science in Europe.

The European Stroke Journal covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor.

We need your active support for the journal in multiple ways: by submitting your best science in the stroke field to the European Stroke Journal, by providing rapid and careful reviews when asked for, by citing the European Stroke Journal publications in your own manuscripts, by spreading the information of the journal to your colleagues, and by promoting the journal in social media. We count on your full support from the very start.

European Stroke Journal

History of the ESJ

In October, ESO President Kennedy Lees announced the launch of its own journal, the European Stroke Journal (ESJ). It is fully peer-reviewed and will be submitted for Committee on Publication Ethics (COPE) membership upon publication of the first issue. Issues will be published 4 times a year (March, June, September and December) with 96 pages in each issue. Articles will be published online first prior to issue publication. Subscription of the European Stroke Journal is included in the ESO membership fee.

The journal is owned by the ESO and published by the highly reputable publishing company SAGE. SAGE publishes a series of medical and scientific journals, is known for its ethical approach.

The Editor-in-Chief is Bo Norrving, from Lund in Sweden. Bo has impeccable credentials for this role. He is a former President of the World Stroke Organisation and has represented stroke at the World Health Organisation. He has been senior consulting editor for Stroke. He brings vast experience and huge commitment to stroke, to Europe and to the task before him. He will handle the political, ethical, scientific and practical aspects with assurance and diplomacy, and will draw huge credit to ESO and ESJ in the process. The Vice Editor is Didier Leys from Lille in France. He has had editorial duties at JNNP for 7 years and also has strong political credentials: he was President of ESO from 2010-2012.